|
Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer |
|
|
|
Titel: |
Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer |
Auteur: |
Hochster, H. S. Uboha, N. Messersmith, W. Gold, P. J. ONeil, B. H. Cohen, D. Denlinger, C. Cohen, S. Leichman, C. G. Leichman, L. |
Verschenen in: |
Cancer, chemotherapy and pharmacology |
Paginering: |
Jaargang 75 (2014) nr. 1 pagina's 17-23 |
Jaar: |
2014 |
Inhoud: |
|
Uitgever: |
Springer Berlin Heidelberg, Berlin/Heidelberg |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|